Clinical Trial

Change in Choroidal Thickness of Myopic Eyes With a Myopia Control Contact Lens

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated March 26, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
In this study, the direct effect of the MiSight contact lens (Cooper Vision), a daily disposable contact lens recently approved in Germany for the treatment of myopia, will be investigated. The aim of this study is to demonstrate an increase in choroidal thickness due to the myopic defocus induced by the contact lens. The increase in choroidal thickness after 30 minutes of exposure to the myopic defocus induced by the contact lens will be demonstrated by measuring the subfoveal and macular choroidal thickness.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-10-08; most recent amendment 2025-03-25.
Trial Details
NCT Number NCT06636019
Lead Sponsor University Hospital Augsburg
Conditions Myopia
Enrollment 10 participants
Start Date 2024-08-13
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-26